Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Psychiatric symptoms, quality of life, and HIV status among people using opioids in Saint Petersburg, Russia.

Desrosiers A, Blokhina E, Krupitsky E, Zvartau E, Schottenfeld R, Chawarski M.

Drug Alcohol Depend. 2017 Mar 1;172:60-65. doi: 10.1016/j.drugalcdep.2016.12.007. Epub 2017 Jan 23.

PMID:
28130990
2.

ASSOCIATION BETWEEN HIV KNOWLEDGE AND RISK BEHAVIOR IN PERSONS WHO INJECT DRUGS IN THAI NGUYEN, VIETNAM.

Lim TW, Davis WW, Quan VM, Frangakis C, Viet T, Minh NL, Latkin C, Zelaya C, Mo TT, Go VF.

Southeast Asian J Trop Med Public Health. 2014 Nov;45(6):1425-36.

3.

High prevalence of syringe lending among HIV-positive people who inject drugs in Bangkok, Thailand.

Voon P, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E, Kerr T.

Harm Reduct J. 2015 Jun 2;12:16. doi: 10.1186/s12954-015-0050-5.

4.

Employment-based abstinence reinforcement following inpatient detoxification in HIV-positive opioid and/or cocaine-dependent patients.

Dunn KE, Fingerhood M, Wong CJ, Svikis DS, Nuzzo P, Silverman K.

Exp Clin Psychopharmacol. 2014 Feb;22(1):75-85. doi: 10.1037/a0034863.

5.

Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study.

Tassiopoulos K, Bernstein J, Bernstein E.

Addict Sci Clin Pract. 2013 Dec 13;8:20. doi: 10.1186/1940-0640-8-20.

6.

Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.

Fu TC, Westergaard RP, Lau B, Celentano DD, Vlahov D, Mehta SH, Kirk GD.

AIDS. 2012 Nov 28;26(18):2383-91. doi: 10.1097/QAD.0b013e32835ad438.

7.

Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors.

Le Marchand C, Evans J, Page K, Davidson PJ, Hahn JA.

Drug Alcohol Depend. 2013 Jan 1;127(1-3):143-9. doi: 10.1016/j.drugalcdep.2012.06.024. Epub 2012 Jul 20.

8.

Is injection serosorting occurring among HIV-positive injection drug users? Comparison by injection partner's HIV status.

Mizuno Y, Purcell DW, Metsch LR, Gomez CA, Knowlton AR, Latka MH.

J Urban Health. 2011 Dec;88(6):1031-43. doi: 10.1007/s11524-011-9578-1.

9.

Does initiation of HIV antiretroviral therapy influence patterns of syringe lending among injection drug users?

Kuyper L, Milloy MJ, Marshall BD, Zhang R, Kerr T, Montaner JS, Wood E.

Addict Behav. 2011 May;36(5):560-3. doi: 10.1016/j.addbeh.2011.01.022. Epub 2011 Jan 21.

10.

Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.

Jenness SM, Hagan H, Liu KL, Wendel T, Murrill CS.

Subst Use Misuse. 2011;46(2-3):192-200. doi: 10.3109/10826084.2011.521467.

11.

Perceived serosorting of injection paraphernalia sharing networks among injection drug users in Baltimore, MD.

Yang C, Tobin K, Latkin C.

AIDS Behav. 2011 Jan;15(1):16-21. doi: 10.1007/s10461-010-9713-0.

12.

HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.

Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman DC, Torian LV, Beatice S, Semaan S, Friedman SR.

Drug Alcohol Depend. 2010 Jun 1;109(1-3):154-60. doi: 10.1016/j.drugalcdep.2009.12.028. Epub 2010 Feb 16.

13.

Secondary prevention of HIV infection: the current state of prevention for positives.

Fisher JD, Smith L.

Curr Opin HIV AIDS. 2009 Jul;4(4):279-87. doi: 10.1097/COH.0b013e32832c7ce5. Review.

14.

Oral complications of HIV disease.

Leao JC, Ribeiro CM, Carvalho AA, Frezzini C, Porter S.

Clinics (Sao Paulo). 2009 May;64(5):459-70. Review.

15.

Social norms, social networks, and HIV risk behavior among injection drug users.

Latkin CA, Kuramoto SJ, Davey-Rothwell MA, Tobin KE.

AIDS Behav. 2010 Oct;14(5):1159-68. doi: 10.1007/s10461-009-9576-4. Epub 2009 May 23.

16.

Predictors of sharing injection equipment by HIV-seropositive injection drug users.

Latkin CA, Buchanan AS, Metsch LR, Knight K, Latka MH, Mizuno Y, Knowlton AR; Intervention for Seropositive Injectors--Research Evaluation Team.

J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):447-50.

17.

Longitudinal analysis of the relationship between perceived norms and sharing injection paraphernalia.

Davey-Rothwell MA, Latkin CA, Tobin KE.

AIDS Behav. 2010 Aug;14(4):878-84. doi: 10.1007/s10461-008-9520-z. Epub 2009 Jan 16.

18.

The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.

Gyarmathy VA, Neaigus A, Mitchell MM, Ujhelyi E.

Drug Alcohol Depend. 2009 Mar 1;100(3):240-7. doi: 10.1016/j.drugalcdep.2008.10.014. Epub 2008 Dec 5.

19.

A randomized intervention trial to reduce the lending of used injection equipment among injection drug users infected with hepatitis C.

Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, Coady MH, Garfein RS, Pu M, Thomas DL, Thiel TK, Strathdee SA.

Am J Public Health. 2008 May;98(5):853-61. doi: 10.2105/AJPH.2007.113415. Epub 2008 Apr 1.

Supplemental Content

Support Center